Delivery Order SPE2DB24D2010-SPE2DB24FZVP3
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,565,153,938 units of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $6,580.88. The contract has a period of performance through July 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of 4,565,099,639 units of the prescription drug Vyvanse (50 mg capsules) to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, valued at $2,579.01, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a firm fixed-price Delivery Order with a completion date of July 10, 2024. Amerisourcebergen holds several...
This federal contract award is for the delivery of 4,564,995,521 units of the pharmaceutical drug Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $1,982.22 and a completion date of June 26, 2024. This appears to be a delivery order under a larger...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,978,188 units of Vyvanse 40 mg capsules. The $1,567.08 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, and has a completion date of June 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award is for the delivery of 4,564,881,676 units of the prescription drug Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $16,404.28. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 12,...
This federal contract award is for the delivery of 4,565,115,883 units of the prescription medication Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a major Defense agency. The $2,578.98 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, without any set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,179,118 units of the prescription drug Vyvanse 30 mg capsules. The $1,150.57 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency, and has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the supply of 4,564,604 units of the prescription medication Vyvanse 30mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,097.86 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. This Delivery Order contract, valued at $3,613.72, has a firm fixed price and an ultimate completion date of May 15, 2024. The contract is not set aside for any special designation. Amerisourcebergen Drug...
This federal contract award is for the delivery of Vyvanse 50mg capsules in 100-count bottles to the Defense Logistics Agency (DLA). The $4,992.76 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 19, 2024. The contract has an ultimate completion date of November 20, 2024 and was not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...